Chemical activators of F-box and WD-40 domain protein 27 (FBXW7) include a variety of compounds that initiate a cascade of intracellular events, leading to the protein's activation via phosphorylation. Phorbol 12-myristate 13-acetate (PMA), for example, is an activator of protein kinase C (PKC), and once PKC is active, it can phosphorylate FBXW7, which is a necessary modification for its activation. Forskolin, by increasing intracellular cAMP levels, indirectly activates protein kinase A (PKA), which can also target FBXW7 for phosphorylation. Similarly, compounds that modulate calcium levels, such as Ionomycin and Thapsigargin, disrupt intracellular calcium balance, leading to the activation of calcium/calmodulin-dependent protein kinases (CaMKs); these kinases can then directly phosphorylate FBXW7. Stress conditions induced by Anisomycin lead to the activation of stress-activated protein kinases (SAPKs) including JNK, which can also contribute to the phosphorylation and activation of FBXW7.
Furthermore, inhibitors of protein phosphatases like okadaic acid and calyculin A prevent dephosphorylation of proteins, thereby maintaining FBXW7 in a phosphorylated, active state. Staurosporine, albeit a kinase inhibitor at higher concentrations, can at lower concentrations activate certain kinases which might then phosphorylate FBXW7. Epigallocatechin gallate (EGCG) and sphingosine, by inhibiting certain protein kinases, can result in the compensatory activation of other kinases that target FBXW7. Bisindolylmaleimide I, while directly inhibiting PKC, can lead to the activation of alternative pathways that activate FBXW7. Lastly, dibutyryl-cAMP, a cAMP analog, activates PKA, enhancing the phosphorylation and subsequent activation of FBXW7. Each of these chemicals, through their interaction with various kinases or kinase pathways, ensures the phosphorylation and activation of FBXW7, playing a critical role in its functional regulation within the cell.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which in turn could phosphorylate F-box and WD-40 domain protein 27 (FBXW7), leading to its functional activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium concentrations, which can activate calcium/calmodulin-dependent protein kinases (CaMKs). CaMKs can then phosphorylate FBXW7, leading to its activation. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid inhibits protein phosphatases PP1 and PP2A, resulting in increased phosphorylation levels of cellular proteins, which could include FBXW7, thus leading to its activation. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Similar to okadaic acid, calyculin A inhibits PP1 and PP2A, maintaining proteins in a phosphorylated state, which could lead to the activation of FBXW7. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the SERCA pump leading to a rise in cytosolic calcium levels, potentially activating CaMKs, which can phosphorylate and activate FBXW7. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates stress-activated protein kinases (SAPKs) such as JNK, which could phosphorylate and activate FBXW7. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
At low concentrations, staurosporine can activate certain kinases, and these activated kinases could phosphorylate FBXW7, promoting its activation. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG inhibits certain protein kinases, which may lead to a compensatory activation of other kinases that could phosphorylate and activate FBXW7. | ||||||
D-erythro-Sphingosine | 123-78-4 | sc-3546 sc-3546A sc-3546B sc-3546C sc-3546D sc-3546E | 10 mg 25 mg 100 mg 1 g 5 g 10 g | $90.00 $194.00 $510.00 $2448.00 $9384.00 $15300.00 | 2 | |
Sphingosine inhibits protein kinase C (PKC), which may lead to the activation of alternative kinases capable of phosphorylating and activating FBXW7. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
This compound is a specific inhibitor of PKC, and its inhibition could lead to the activation of compensatory pathways that phosphorylate and activate FBXW7. | ||||||